EUVIMEDOpdag EUVIMED
Fallbericht

Successful Thrombolysis of an Obstructive Prosthetic Mitral Valve Thrombosis Using Alteplase

Govindaraj Varadaraj, Kiran Maribashetti, R Ananthakrishnan, Binoy Michael

Journal of The Association of Physicians of India · 2024

DOI: 10.59556/japi.72.0567 ↗

At a glance

Fallbericht in Journal of The Association of Physicians of India, 2024. Written by Govindaraj Varadaraj and 3 co-authors. Institution: Assistant Professor, Department of General Medicine, Air Force Central Medical Establishment, Delhi, India, Corresponding Author. Major MEDLINE topics: Tissue Plasminogen Activator, Fibrinolytic Agents, Thrombosis, Heart Valve Prosthesis. 8 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

A 48-year-old man with a history of mitral valve replacement (MVR) in March 2019 for rheumatic heart disease (RHD) and ischemic stroke in August 2019 presented with a history of sudden onset angina of 6 hours duration. He admits to defaulting oral anticoagulant (OAC) intake for the last 50 days. On arrival, he had atrial fibrillation with hemodynamic instability [blood pressure (BP) 70/40 mm Hg, saturation of peripheral oxygen (SpO2) 80% at room air and heart rate approx 140/minute], which was managed with intravenous diltiazem and hemodynamic stability achieved (BP 116/72 mm Hg, heart rate 86/minute). Urgent transthoracic echocardiogram (TTE) and fluoroscopy confirmed obstructive prosthetic mitral valve thrombosis. Though available recommendations suggest surgical intervention for the left-sided valve involvement in a stable patient, in view of the nonavailability of a surgical facility, the patient was thrombolyzed with Alteplase, a recombinant tissue plasminogen activator (rtPA). Since the patient was stable, a "long fibrinolytic protocol" of Alteplase 10 mg bolus, 50 mg during the 1st hour, and 20 mg each during the 2nd and 3rd hour (total of 100 mg) was given. Subsequent TTE revealed a mean gradient of 5 mm Hg, and cine fluoroscopy showed improved mitral valve motion, thereby indicating successful thrombolysis. The patient felt symptomatically relieved within 6 hours and is presently on OAC therapy with strict drug compliance.

Subjects

MeSH terms (MEDLINE)

Tissue Plasminogen ActivatorFibrinolytic AgentsThrombosisHeart Valve ProsthesisMitral ValveHumansMaleMiddle AgedThrombolytic TherapyRheumatic Heart DiseaseEchocardiography

Substances

Tissue Plasminogen ActivatorFibrinolytic Agents

Authors and institutions

  • Assistant Professor, Department of General Medicine, Air Force Central Medical Establishment, Delhi, India, Corresponding Author.
  • Assistant Professor, Department of General Medicine, Command Hospital Western Command, Panchkula, Haryana, India.
  • Professor, Department of General Medicine, INHS Asvini, Mumbai, Maharashtra, India.
  • Assistant Professor, Department of Anesthesia, 425 Field Hospital, Poonch, Jammu and Kashmir, India.

Cite

APA

Varadaraj, G., Maribashetti, K., Ananthakrishnan, R., & Michael, B. (2024). Successful Thrombolysis of an Obstructive Prosthetic Mitral Valve Thrombosis Using Alteplase. Journal of The Association of Physicians of India. https://doi.org/10.59556/japi.72.0567

Vancouver

Varadaraj G, Maribashetti K, Ananthakrishnan R, Michael B. Successful Thrombolysis of an Obstructive Prosthetic Mitral Valve Thrombosis Using Alteplase. Journal of The Association of Physicians of India. 2024. doi:10.59556/japi.72.0567

BibTeX
@article{Varadaraj2024,
  author = {Varadaraj, Govindaraj and Maribashetti, Kiran and Ananthakrishnan, R and Michael, Binoy},
  title = {Successful Thrombolysis of an Obstructive Prosthetic Mitral Valve Thrombosis Using Alteplase},
  journal = {Journal of The Association of Physicians of India},
  year = {2024},
  doi = {10.59556/japi.72.0567}
}
Start for free →